Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
letter
. 2021 Mar 13;225(1):95–99. doi: 10.1016/j.ajog.2021.03.015

Prioritization of pregnant individuals in state plans for coronavirus disease 2019 vaccination

Matthew A Crane 1,2, Elana Jaffe 3,4, Richard H Beigi 5, Ruth A Karron 6, Carleigh B Krubiner 7, Chizoba B Wonodi 8, Ruth R Faden 9
PMCID: PMC7955581  PMID: 33727113

Objective

The US Centers for Disease Control and Prevention (CDC) considers pregnant people to be at high-risk for severe disease and death from coronavirus disease 2019 (COVID-19), and the Advisory Committee on Immunization Practices (ACIP) recommends that pregnant individuals should be prioritized for vaccination in Phase 1c of vaccine allocation.1 However, various state vaccination plans have not been uniform in the adoption of the ACIP priority group recommendations. Prior research found 15 states included pregnancy among other COVID-19 priority groups,2 but planning has been highly dynamic in recent weeks. The objectives of this study were to determine how many states prioritize pregnant individuals for COVID-19 vaccination and assess the current eligibility of pregnant people to receive COVID-19 vaccinations across the United States.

Study Design

We searched for information about the priority groups for COVID-19 vaccinations from all 50 states in the United States and the District of Columbia on March 6, 2021. Our analysis included information from official government websites. This study did not require institutional review board approval because it examined data from publicly available sources and used no patient information.

Results

As of March 6, 2021, most states (36 of 51; 73%) classified pregnant individuals as a priority group for COVID-19 vaccination; in just under 50% of the states (24 of 51), pregnant people are currently eligible for vaccination (Table ). The 36 states prioritizing pregnancy encompass 76% of the US population. Of these states, 23 refer to the CDC’s classification of pregnant people as being at an elevated risk for severe COVID-19 illness. Several states (9 of 51; 18%) prioritize groups at elevated risk for severe COVID-19 illness because of preexisting health conditions but have not specifically enumerated pregnant people as a priority group. Four states have designed their prioritization plan around an age-descending strategy, and 2 states list only current or near eligible groups, and pregnant people are not included.

Table.

State prioritization of pregnant individuals for coronavirus disease 2019 vaccination

State Priority (phase)a Current eligibilityb Populationc Source
Alabama Yes (1c) No 4,903,185 https://www.alabamapublichealth.gov/covid19vaccine/distribution.html
Alaska Yes (1b) Yes 731,545 http://dhss.alaska.gov/dph/epi/id/pages/COVID-19/vaccine.aspx
Arizonad No No 7,278,717 https://azgovernor.gov/governor/news/2021/03/state-adopts-unique-hybrid-model-covid-19-vaccine-prioritization
Arkansas Yes (1c) No 3,017,804 https://www.healthy.arkansas.gov/programs-services/topics/covid-19-vaccination-plan
California Yes (1c) No 39,512,223 https://covid19.ca.gov/vaccines/#California's-vaccination-plan
Colorado Yes (1b) Yes 5,758,736 https://covid19.colorado.gov/for-coloradans/vaccine/vaccine-for-coloradans
Connecticut No No 3,565,287 https://portal.ct.gov/vaccine-portal/COVID-19-Vaccination-Phases
Delaware No No 973,764 https://coronavirus.delaware.gov/vaccine/vaccination-timeline/#phase-1b
Florida No No 21,477,737 https://floridahealthcovid19.gov/covid-19-vaccines-in-florida/
Georgia No No 10,617,423 https://dph.georgia.gov/covid-vaccine
Hawaii No No 1,415,872 https://hawaiicovid19.com/vaccine/#first-vaccines
Idaho No No 1,787,065 https://healthandwelfare.idaho.gov/covid-19-vaccination
Illinois Yes (1b+) Yes 12,671,821 https://www.dph.illinois.gov/covid19/vaccine-distribution
Indiana No No 6,732,219 https://www.coronavirus.in.gov/vaccine/index.htm
Iowa Yes (1b) Yes 3,155,070 https://idph.iowa.gov/Emerging-Health-Issues/Novel-Coronavirus/Vaccine/Information-for-the-Public
Kansas Yes (3) No 2,913,314 https://www.kansasvaccine.gov/157/Availability
Kentucky Yes (1c) Yes 4,467,673 https://govstatus.egov.com/ky-covid-vaccine
Louisiana Yes (1b) Yes 4,648,794 https://ldh.la.gov/index.cfm/faq/category/138
Maine No No 1,344,212 https://www.maine.gov/covid19/vaccines/phases
Maryland No No 6,045,680 https://covidlink.maryland.gov/content/vaccine/
Massachusetts Yes (2) Yes 6,892,503 https://www.mass.gov/info-details/covid-19-vaccinations-for-individuals-with-certain-medical-conditions
Michigan Yes (1c) No 9,986,857 https://www.michigan.gov/documents/coronavirus/MI_COVID-19_Vaccination_Prioritization_Guidance_2152021_716344_7.pdf
Minnesota Yes (1b) No 5,639,632 https://www.health.state.mn.us/diseases/coronavirus/vaccine/phase1b1c2.pdf
Mississippi Yes Yes 2,976,149 https://msdh.ms.gov/msdhsite/_static/14,22816,420,976.html
Missouri Yes (1b) Yes 6,137,428 https://covidvaccine.mo.gov/priority/Phase1b/#phase1b-2
Montana No No 1,068,778 https://dphhs.mt.gov/publichealth/cdepi/diseases/coronavirusmt/covid19vaccineavailability
Nebraska No No 1,934,408 https://dhhs.ne.gov/Pages/COVID-19-Vaccine-Information.aspx#SectionLink2
Nevada Yes Yes 3,080,156 https://www.immunizenevada.org/county-specific-covid-19-vaccine-plan
New Hampshire Yes (1b) Yes 1,359,711 https://www.dhhs.nh.gov/dphs/cdcs/covid19/documents/covid19-vaccine-allocation-plan-summary.pdf
New Jersey Yes (1b) Yes 8,882,190 https://covid19.nj.gov/faqs/nj-information/slowing-the-spread/who-is-eligible-for-vaccination-in-new-jersey-who-is-included-in-the-vaccination-phases
New Mexico Yes (1b) Yes 2,096,829 https://cv.nmhealth.org/wp-content/uploads/2021/02/2021.1.28-DOH-Phase-Guidance.pdf
New York Yes (1b) Yes 19,453,561 https://covid19vaccine.health.ny.gov/phased-distribution-vaccine#phase-1a---phase-1b
North Carolina Yes (group 4) No 10,488,084 https://covid19.ncdhhs.gov/vaccines/providers/covid-19-vaccine-management-system-cvms
North Dakota Yes (1b) Yes 762,062 https://www.health.nd.gov/covid-19-vaccine-priority-groups
Ohio Yes (1c) Yes 11,689,100 https://coronavirus.ohio.gov/wps/portal/gov/covid-19/covid-19-vaccination-program
Oklahoma No No 3,956,971 https://oklahoma.gov/covid19/vaccine-information.html
Oregon Yes (1b) Yes 4,217,737 https://sharedsystems.dhsoha.state.or.us/DHSForms/Served/le3527A.pdf
Pennsylvania Yes (1a) Yes 12,801,989 https://www.health.pa.gov/topics/disease/coronavirus/Vaccine/Pages/Distribution.aspx
Rhode Island Yes No 1,059,361 https://health.ri.gov/publications/guidelines/COVID19-underlying-conditions.pdf
South Carolina Yes (1b) No 5,148,714 https://scdhec.gov/covid19/covid-19-vaccine
South Dakota Yes (1d) Yes 884,659 https://doh.sd.gov/documents/COVID19/Vaccine/COVIDVaccineAvailability_Distribution.pdf
Tennessee Yes (1c) No 6,829,174 https://covid19.tn.gov/covid-19-vaccines/vaccine-phases/#1c
Texas Yes (1b) Yes 28,995,881 https://www.dshs.texas.gov/coronavirus/immunize/vaccine.aspx#eligible
Utah No No 3,205,958 https://coronavirus.utah.gov/vaccine-distribution/#eligibility
Vermont Yes (5A) No 623,989 https://www.healthvermont.gov/covid-19/vaccine/about-covid-19-vaccines-vermont#conditions
Virginia Yes (1b) Yes 8,535,519 https://www.vdh.virginia.gov/covid-19-vaccine/#phase1b
Washington Yes (1b) No 7,614,893 https://www.doh.wa.gov/Emergencies/COVID19/VaccineInformation/AllocationandPrioritization
Washington D.C. Yes (1c) Yes 705,749 https://coronavirus.dc.gov/vaccine
West Virginia Yes (2a) Yes 1,792,147 https://dhhr.wv.gov/COVID-19/Pages/Vaccine.aspx#timeline
Wisconsin No No 5,822,434 https://www.dhs.wisconsin.gov/covid-19/vaccine-about.htm
Wyoming Yes (1b) Yes 578,759 https://health.wyo.gov/publichealth/immunization/wyoming-covid-19-vaccine-information/

Results of the review of state prioritization planning for pregnant individuals. Data were collected on March 6, 2021, and may not represent recent changes in planning or eligibility.

COVID-19, coronavirus disease 2019.

Crane. Prioritization of pregnant individuals in state plans for coronavirus disease 2019 vaccination. Am J Obstet Gynecol 2021.

a

Phase listed refers to the first phase or subphase in which pregnant individuals are prioritized for vaccination. These have been rounded to the nearest subphase when divided into subphase tiers. States which do not follow a clear, phased approach to vaccination but still prioritize pregnant individuals are listed only as “Yes.” When pregnant individuals are prioritized across multiple phases, they are listed here under the earliest phase in which they are enumerated

b

Eligibility varies in some states at the county level. Results here refer to eligibility of pregnant individuals in at least some counties within a state, even if there are additional requirements such as multiple, high-risk health states or an age threshold. States were not enumerated if they rely on reference from a physician to determine vulnerability to COVID-19 without specific mention of pregnancy

c

Population counts obtained from 2019 US Census Bureau Data (https://www.census.gov/newsroom/press-kits/2019/national-state-estimates.html)

d

At the time of plan analysis, Arizona was transitioning toward an age-based approach to COVID-19 vaccine eligibility and not all government resources had been updated to reflect this policy adjustment. Our analysis reflects the anticipated age-based approach.

Conclusion

Most states classify pregnant individuals as a priority group for initial COVID-19 vaccinations, and in almost 50% of the states, they are currently eligible to receive vaccines. These results differ substantially from previous findings published in early February 2021, which found that 15 of the 51 jurisdictions had prioritized pregnant individuals.2 The increased prioritization of pregnant people for COVID-19 vaccination marks important progress—it is both ethically imperative and supported by recommendations from professional US obstetrics societies and the CDC.3 , 4 Continued efforts to ensure equitable access to COVID-19 vaccines for pregnant people require, at minimum, that all states prioritize pregnancy as equal with the CDC-listed, high-risk health conditions based on the available, objective data.

Even where pregnant people are eligible for COVID-19 vaccinations, personal decision making is complicated by the overall lack of pregnancy-specific safety data. Vaccine studies among pregnant people are underway and early registry data are reassuring. To date, pregnancy outcomes among nearly 2000 vaccinated pregnant people are no different from those in the general population, suggesting that the messenger RNA vaccines have no adverse effects on pregnancy.5 Pregnant people deserve the clearest possible guidance from public health agencies about their eligibility for COVID-19 vaccinations and whether the likely benefits of vaccination during pregnancy outweigh the risks.

Footnotes

The authors report no conflict of interest.

This study received no financial support.

References


Articles from American Journal of Obstetrics and Gynecology are provided here courtesy of Elsevier

RESOURCES